Orgenesis Inc. Reports Material Definitive Agreement & Financial Obligations
Ticker: ORGS · Form: 8-K · Filed: Nov 5, 2024 · CIK: 1460602
| Field | Detail |
|---|---|
| Company | Orgenesis INC. (ORGS) |
| Form Type | 8-K |
| Filed Date | Nov 5, 2024 |
| Risk Level | medium |
| Pages | 6 |
| Reading Time | 7 min |
| Key Dollar Amounts | $2,049,315, $1.03, $500,000, $250,000, $15 m |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement, financial-obligation, equity-sale
TL;DR
Orgenesis Inc. signed a new deal, took on debt, and sold stock on Oct 31st. Big financial moves!
AI Summary
On October 31, 2024, Orgenesis Inc. entered into a material definitive agreement related to its financial obligations. The company also reported on the creation of a direct financial obligation and unregistered sales of equity securities. This filing provides details on these significant financial events and includes financial statements and exhibits.
Why It Matters
This filing indicates significant financial activity for Orgenesis Inc., including new obligations and equity sales, which could impact its financial structure and future operations.
Risk Assessment
Risk Level: medium — The filing details material definitive agreements, financial obligations, and unregistered equity sales, which can introduce financial risks and uncertainties.
Key Players & Entities
- Orgenesis Inc. (company) — Registrant
- October 31, 2024 (date) — Date of earliest event reported
- Nevada (jurisdiction) — State of incorporation
- 001-38416 (identifier) — Commission File Number
- 98-0583166 (identifier) — IRS Employer Identification No.
FAQ
What type of material definitive agreement did Orgenesis Inc. enter into?
The filing indicates the entry into a material definitive agreement but does not specify the exact nature of the agreement in the provided text.
What is the significance of the 'Creation of a Direct Financial Obligation' item?
This item signifies that Orgenesis Inc. has incurred a new direct financial commitment or liability.
What does 'Unregistered Sales of Equity Securities' imply for Orgenesis Inc.?
This suggests that Orgenesis Inc. has issued new shares of its stock without registering them with the SEC, which may have implications for existing shareholders and regulatory compliance.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on October 31, 2024.
What is Orgenesis Inc.'s state of incorporation and fiscal year end?
Orgenesis Inc. is incorporated in Nevada, and its fiscal year ends on December 31.
Filing Stats: 1,786 words · 7 min read · ~6 pages · Grade level 12.1 · Accepted 2024-11-05 16:05:22
Key Financial Figures
- $2,049,315 — ipal amount of the loan outstanding was $2,049,315 with interest of 8% per annum (based on
- $1.03 — tock, at an exercise price per share of $1.03 per share, which is exercisable until o
- $500,000 — uant to which Nir agreed to loan Koligo $500,000 (the "Loan") with an effective date of
- $250,000 — ender agreed to loan Orgenesis Maryland $250,000 (the "Loan Amount"). The Loan Amount sh
- $15 m — an aggregate gross proceeds of at least $15 million, the Note holder may require repa
- $10.30 — of common stock held by the Lender from $10.30 to $1.03 per share. The Note contains
Filing Documents
- form8-k.htm (8-K) — 53KB
- ex10-1.htm (EX-10.1) — 20KB
- ex10-2.htm (EX-10.2) — 37KB
- ex10-3.htm (EX-10.3) — 48KB
- 0001493152-24-043658.txt ( ) — 349KB
- orgs-20241031.xsd (EX-101.SCH) — 3KB
- orgs-20241031_lab.xml (EX-101.LAB) — 33KB
- orgs-20241031_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ORGENESIS INC. Date: November 5, 2024 By: /s/ Victor Miller Victor Miller Chief Financial Officer, Treasurer and Secretary